Immunotherapy Drugs Market Share

Statistics for the 2023 & 2024 Immunotherapy Drugs market share, created by Mordor Intelligence™ Industry Reports. Immunotherapy Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Suppressants Research Immunosuppressives Research Immunotherapy Drugs Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Immunotherapy Drugs Industry

The immunotherapy drugs market is moderately fragmented and consists of several major players. In terms of market share, few of the major players currently dominate the market. The market players are focusing on new product launches, R&D, and expansions to gain a competitive advantage. Some of the market's major players include AbbVie Inc., Amgen Inc., AstraZeneca, GlaxoSmithKline PLC, Novartis AG, and F. Hoffmann-La Roche AG.

Immunotherapy Drugs Market Leaders

  1. GlaxoSmithKline plc

  2. Amgen Inc.

  3. Novartis AG

  4. AbbVie Inc.

  5. F. Hoffmann-La Roche AG

*Disclaimer: Major Players sorted in no particular order

Immunotherapy Drugs Market Concentration

Immunotherapy Drugs Market Report Snapshots

Immunotherapy Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)